Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis—Roles as Putative Treatment Targets?

Hepatic fibrosis is the primary predictor of mortality in patients with non-alcoholic steatohepatitis (NASH). In this process, the activated hepatic stellate cells (HSCs) constitute the principal cells responsible for the deposition of a fibrous extracellular matrix, thereby driving the hepatic scar...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Alexandra Zisser, David H. Ipsen, Pernille Tveden-Nyborg
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2021-03-01
סדרה:	Biomedicines
נושאים:	non-alcoholic fatty liver disease non-alcoholic steatohepatitis fibrosis hepatic stellate cells HSC activation HSC inactivation
גישה מקוונת:	https://www.mdpi.com/2227-9059/9/4/365
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!